Zaguirre, Baby Girl .

HRN: 27-96-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2025
CEFOTAXIME 500MG (VIAL)
10/15/2025
10/22/2025
IV
60mg
Q8
Multiple CHD
Waiting Final Action 
10/15/2025
MUPIROCIN 2%, 15G (TUBE)
10/15/2025
10/22/2025
TOPICAL
2%
Bid
Previous Injection Site
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: